CrystalGenomics, ProQuest create new drug-development JV, Palkion
February 26, 2008 | David P. Hamilton
See our story about Emeryville, Calif.-based CrystalGenomics and its new JV in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Updated: Is Take-Two distracting Electronic Arts from opportunities like Facebook gaming?
Previous Story: TidalTV to create professionally produced video content on the web, secures $15M
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.












